Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Public ClinicalTrials.gov record NCT01418339. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Flexible-Dose Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of the current study is to determine efficacy and safety of once-weekly aripiprazole in reducing Total Tic Severity (TTS) score in children and adolescents with Tourette's Disorder.
Study identification
- NCT ID
- NCT01418339
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 135 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2011 (Actual)
- Primary completion
- Nov 6, 2013 (Actual)
- Completion
- Nov 6, 2013 (Actual)
- Last update posted
- Oct 7, 2021
2011 – 2013
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Sacramento | California | 95815 | — |
| Not listed | Santa Ana | California | 92701 | — |
| Not listed | Wildomar | California | 92595 | — |
| Not listed | Hialeah | Florida | 33012 | — |
| Not listed | Orange City | Florida | 32763 | — |
| Not listed | St. Petersburg | Florida | 33701 | — |
| Not listed | Overland Park | Kansas | 66211 | — |
| Not listed | New Orleans | Louisiana | 70114 | — |
| Not listed | Bloomfield Hills | Michigan | 48302 | — |
| Not listed | Staten Island | New York | 10312 | — |
| Not listed | Avon Lake | Ohio | 44012 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Middleburg Heights | Ohio | 44130 | — |
| Not listed | Philadelphia | Pennsylvania | 19139 | — |
| Not listed | Dallas | Texas | 75230 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | San Antonio | Texas | 78258 | — |
| Not listed | Salt Lake City | Utah | 84107 | — |
| Not listed | Bothell | Washington | 98011 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01418339, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 7, 2021 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01418339 live on ClinicalTrials.gov.